Latest News and Press Releases
Want to stay updated on the latest news?
-
Curonix Publishes Results for IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA Expanded Indication for Treating Chronic Craniofacial Pain
-
Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution
-
Curonix LLC proudly introduces NervPulseTherapy, an advanced, evidence-based programming platform designed to optimize peripheral nerve stimulation.
-
Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines
-
Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System.
-
Medical Device Leader SPR Therapeutics again named a Top Workplace in Northeast Ohio
-
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
-
SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT PNS System for Low Back Pain
-
POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary. In November 2022, Curonix completed the...
-
POMPANO BEACH, Fla., June 07, 2023 (GLOBE NEWSWIRE) -- Curonix LLC, a medical technology company dedicated to freeing patients from chronic pain, announced the publication of 24 months of data from...